Surge
Benjamin Choisy is the current Chief Product Manager at Surge2Surgery. Prior to this, they worked as an Interne en médecine at APHM (Assistance Publique - Hopitaux de Marseille) from September 2017 to November 2021. Before that, they worked as a medical student at CHU de Toulouse from September 2011 to November 2017.
Benjamin Choisy has a background in immunology from Stanford University. Benjamin also has a Master 2 in both Medicine and Pathologies métaboliques et vasculaires from Aix-Marseille Université. Benjamin is also certified in C1 english level (CLES 3).
They are on a team with Franck Verdonk - Chief Medical Officer, New recruitment - VP Quality and Regulatory Affairs, and Brice Gaudillière - Co-Founder and Scientific Advisor to the CEO. Their manager is Julien Hedou, Chief Executive Officer.
This person is not in the org chart
This person is not in any offices
Surge
1 followers
Surge believes that fingerprinting the immune system can be a game-changer when it comes to improving the surgical journey for millions of patients.